VIRAGEN EUROPE LTD
10-K405, EX-11, 2000-09-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VIRAGEN EUROPE LTD, 10-K405, 2000-09-28
Next: VIRAGEN EUROPE LTD, 10-K405, EX-21, 2000-09-28



<PAGE>   1

                                                                      EXHIBIT 11

                      COMPUTATION OF LOSS PER COMMON SHARE

<TABLE>
<CAPTION>
                                                                    YEAR ENDED JUNE 30,
                                                          ---------------------------------------
                                                             2000          1999          1998
                                                          -----------   -----------   -----------
<S>                                                       <C>           <C>           <C>
Basic and diluted weighted average common shares........   17,046,066    10,607,393     7,116,059
                                                          ===========   ===========   ===========
Net loss................................................  $(6,373,273)  $(4,930,453)  $(4,642,126)
                                                          ===========   ===========   ===========
Basic and diluted net loss per common share.............  $     (0.37)  $     (0.46)  $     (0.65)
                                                          ===========   ===========   ===========
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission